1. Subsequent Chemotherapy Regimens Are Well Tolerated After Radioimmunotherapy With Yttrium-90 Ibritumomab Tiuxetan for Non-Hodgkin’s Lymphoma
2. New approach to classifying non‐Hodgkin's lymphomas: clinical features of the major histological subtypes;Armitage JO;Journal of Clinical Oncology,1998
3. Sphingosomal vincristine plus rituximab for treatment of large B‐cell lymphoma;Ashcroft AJ;Proceedings of the American Society of Hematology,2003
4. A Phase II study of bortezomib in patients with mantle‐cell lymphoma;Assouline S;Proceedings of the American Society of Hematology,2003
5. The pathology of Hodgkin's disease;Banks PM;Seminar Oncology,1990